News

SCIEX, a global leader in life science analytical technologies and operating company of Danaher Corporation (NYSE: DHR), and ...
It’s GlycoEra’s time to shine. The biotech has closed a series B fundraise clocking in at $130 million, with the funds set to ...
The startup is the latest beneficiary of investors’ appetite for protein-degrading technology, which offers a way to reach ...
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by ...
In 2025, the global proteose peptone market is anticipated to be worth USD 151.4 million, with projections indicating a rise ...
ProteinQure raises $11M Series A led by Heron Rock to advance PQ203, a peptide-drug conjugate for triple-negative breast ...
Cvictus recently received a $1.7 million grant from the Bill & Melinda Gates Foundation to scale its technology.
Sichuan Kelun-Biotech Biopharmaceutical Co. Ltd. has identified radiolabeled or nonradiolabeled compounds acting as fibroblast activation protein-α (FAPα) inhibitors reported to be useful for the ...
The discovery of recombinant DNA proved that biology, not chemistry alone, could create new medicines like life-saving ...
At the recent F&A Next conference in Wageningen, the Feike Sijbesma Sustainable Innovation Award 2025 was granted to two ...
The global protein expression market growth forecasted to transform from USD 3.41 billion in 2024 to USD 4.82 billion by 2029, driven by a CAGR of 7.1%. Factors such as the rise i ...
Job cuts at home-grown pharma companies like Arvinas and RallyBio and federal policies challenge CT biotech 'ecosystem' that ...